LINCOLN.NSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 18:59):

Stats
本日の出来高	34 886.00
平均出来高	95 680.00
時価総額	11.43B
EPS	INR0 ( 2024-02-08 )
次の収益日	( INR0 ) 2024-05-22
Last Dividend	INR1.500 ( 2023-09-15 )
Next Dividend	INR0 ( N/A )
P/E	13.09
ATR14	INR1.332 (0.23%)

ボリューム相関

長: 0.24 (neutral)

短: 0.75 (moderate)

Signal:(48.718) Neutral

Lincoln Pharmaceuticals 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Lincoln Pharmaceuticals 相関 - 通貨/商品

-0.27
( neutral )

-0.74
( moderate negative )

0.14
( neutral )

-0.65
( moderate negative )

-0.70
( moderate negative )

0.73
( moderate )

Lincoln Pharmaceuticals 財務諸表

Annual	2022
収益:	INR5.10B
総利益:	INR2.69B (52.70 %)
EPS:	INR36.40

FY	2022
収益:	INR5.10B
総利益:	INR2.69B (52.70 %)
EPS:	INR36.40

FY	2022
収益:	INR4.68B
総利益:	INR2.48B (53.06 %)
EPS:	INR34.63

FY	2021
収益:	INR4.15B
総利益:	INR2.16B (52.05 %)
EPS:	INR31.11

Financial Reports:

No articles found.

Lincoln Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR1.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR1.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Lincoln Pharmaceuticals Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.60 - low (52.89%) | Divividend Growth Potential Score: 5.25 - Stable (5.04%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.000	2016-09-23
Last Dividend	INR1.500	2023-09-15
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	8	--
Total Paid Out	INR11.20	--
Avg. Dividend % Per Year	0.32%	--
Score	2.19	--
Div. Sustainability Score	4.60
Div.Growth Potential Score	5.25
Div. Directional Score	4.93	--

Next Divdend (Est)
(2024-06-25)

INR1.526 Estimate 3.10 %

Dividend Stability

0.25 Very Poor

Dividend Score

2.19

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR1.500	0.67%
2019	INR1.500	0.66%
2020	INR1.500	0.73%
2021	INR1.500	0.62%
2022	INR1.500	0.41%
2023	INR1.500	0.42%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SHRIPISTON.NS	Dividend Junior	2023-06-27	Semi-Annually	9	0.89%
MATRIMONY.NS	Dividend Junior	2023-08-03	Annually	7	0.41%
GRWRHITECH.NS	Dividend Junior	2023-09-20	Semi-Annually	3	0.88%
BANDHANBNK.NS	Dividend Junior	2023-08-11	Sporadic	7	0.20%
PPAP.NS	Ex Dividend Junior	2023-09-08	Annually	17	0.34%
JWL.NS	Dividend Junior	2023-09-12	Insufficient data to determine frequency	2	0.17%
DSSL.NS	Dividend Junior	2023-08-23	Annually	6	0.34%
ACE.NS	Dividend Junior	2023-08-17	Annually	18	0.23%
SSWL.NS	Dividend Junior	2023-08-14	Annually	20	0.30%
MSUMI.NS	Dividend Junior	2023-08-09	Annually	3	0.60%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.159	1.500	6.83	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.166	1.500	9.26	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	47.50	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	10.34	2.00	6.55	10.00	[0 - 30]
freeCashFlowPerShareTTM	10.34	2.00	4.83	9.66	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.487	1.000	5.22	5.22	[0.2 - 0.8]
operatingProfitMarginTTM	0.182	1.000	8.35	8.35	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.60

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	13.35	1.000	8.75	0	[1 - 100]
returnOnEquityTTM	0.166	2.50	9.53	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	10.34	2.00	6.55	9.66	[0 - 30]
dividendYielPercentageTTM	0.258	1.500	3.55	0	[0 - 0.4]
operatingCashFlowPerShareTTM	10.34	2.00	6.55	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	2.61	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0376	1.000	-1.560	0	[0.1 - 0.5]
Total Score				5.25

Lincoln Pharmaceuticals

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative. The company also offers branded generics. Lincoln Pharmaceuticals Limited was founded in 1979 and is based in Ahmedabad, India.